Real-time enrollment status for this alpha-1 antitrypsin deficiency clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:40 PM UTC
| NCT Number | NCT00500123 |
| Recruiting Status | Recruiting |
| Condition | Alpha-1 Antitrypsin Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 50,000 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Florida |
| Last Updated on CT.gov | November 24, 2025 (Nov 24, 2025) |
As of July 17, 2026: Clinical trial NCT00500123 is currently recruiting participants. This clinical trial study for alpha-1 antitrypsin deficiency is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Florida. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT00500123 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT00500123 was last updated Nov 24, 2025 (November 24, 2025). HelloStudys verifies this status automatically.